| 000 -LEADER |
|---|
| fixed length control field |
02614cam a22002294a 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
1588295648 (alk. paper) |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994061 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Immunotherapy of cancer / |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication |
Totowa, N.J. : |
| Name of publisher |
Humana Press, |
| Year of publication |
c2006. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Number of Pages |
xii, 516 p. : |
| Other physical details |
ill. ; |
| 490 0# - SERIES STATEMENT |
|---|
| Series statement |
Cancer drug discovery and development |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Discovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches -- Current strategies for the identification of immunogenic epitopes of tumor antigens -- Current and future role of natural-killer cells in cancer immunotherapy -- The role of immune monitoring in evaluating cancer immunotherapy -- Statistical analysis of immune response assays -- DNA vaccines for cancer immunotherapy -- Dendritic cells -- Different approaches to dendritic cell-based cancer immunotherapy -- Anti-idiotype antibody vaccines for the immunotherapy of cancer -- Autologous tumor-derived heat shock protein vaccine as a new paradigm for individualized cancer therapeutics -- Tumor-reactive T-cells for adoptive immunotherapy -- T-cell adoptive immunotherapy of cancer: from translational models to clinical significance -- Retroviral-mediated gene transfer for engineering tumor-reactive T-cells -- Harnessing the potential of graft-vs-tumor -- Tumor-induced immune suppression and immune escape: mechanisms and impact on the outcome of immunotherapy of malignant disease -- The tumor microenvironment: regulation of antitumor immunity and implications for immunotherapy -- Manipulation of lymphocyte homeostasis for enhancing antitumor immunity -- Fast-lane evolution in the tumor microenvironment -- Manipulating immunological checkpoints to maximize antitumor immunity -- Interleukin-2 as cancer therapy -- Biological and clinical properties of the type 1 interferons -- Promising g [gamma]-chain cytokines for cancer immunotherapy: interleukins-7, -15, and -21 as vaccine adjuvants, growth factors -- The therapeutic use of natural-killer cells in hematological malignancies -- Antibody therapy for solid tumors -- Antibody therapy for non-Hodgkin's lymphoma -- Approaches to in vivo imaging of cancer immunotherapy -- Design issues for early-stage clinical trials for cancer vaccines -- Monoclonal antibody therapy for cancer. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical Term |
Cancer |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical Term |
Antineoplastic agents |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical Term |
Neoplasms |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical Term |
Neoplasms |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical Term |
Immunotherapy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Disis, Mary L. |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://www.loc.gov/catdir/toc/ecip0514/2005017065.html |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://www.loc.gov/catdir/enhancements/fy0825/2005017065-d.html |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Books |
